Effect of different preparations of hormone therapy on lipid and glucose metabolism, coagulation factors, and bone mineral density in overweight and obese postmenopausal women

Fertility and Sterility

Volumn 84, Issue 2, 2005, Pages 384-393

  Osmanaǧaoǧlu, Mehmet A ^a   Osmanaǧaoǧlu, Selen ^a   Osmanaǧaoǧlu, Tayfun ^b   Okumuş, Bakiye ^a   Bozkaya, Hasan ^a  

^a KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

^b ACIBADEM HOSPITAL   (Turkey)

Author keywords

Body mass index; Bone mineral density; Coagulation factors; Glucose metabolism; Hormone therapy; Lipid profile; Postmenopause

Indexed keywords

ANTITHROMBIN III; BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; CHOLESTEROL; CONJUGATED ESTROGEN; ESTRADIOL PLUS NORETHISTERONE ACETATE; ESTROGEN; FIBRINOGEN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEDROXYPROGESTERONE ACETATE; PROTEIN C; PROTEIN S; TIBOLONE; TRIACYLGLYCEROL; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; BODY MASS; BONE DENSITY; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FIBRINOGEN BLOOD LEVEL; GLUCOSE METABOLISM; HORMONAL THERAPY; HUMAN; LIPID METABOLISM; LUMBAR SPINE; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; OBESITY; OUTCOMES RESEARCH; POSTMENOPAUSE; PREDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; BLOOD COAGULATION FACTORS; BLOOD GLUCOSE; BODY MASS INDEX; BONE DENSITY; CONTRACEPTIVES, ORAL, SYNTHETIC; ESTROGEN REPLACEMENT THERAPY; ESTROGENS, CONJUGATED (USP); FEMALE; HUMANS; LIPIDS; MEDROXYPROGESTERONE; MIDDLE AGED; NORETHINDRONE; NORPREGNENES; OBESITY; OVERWEIGHT; PHARMACEUTICAL PREPARATIONS; POSTMENOPAUSE;

EID: 23744497182     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2005.01.131     Document Type: Article

References (48)

1. M. Gambacciani, M. Ciaponi, B. Cappagli, L. Piaggesi, L. De Simone, R. Orlandi Body weight, body fat distribution, and hormonal replacement therapy in early postmenopausal women J Clin Endocrinol Metab 82 1997 414 417
2. W.T. Cefalu, Z.Q. Wang, S. Werbel, A. Bell-Farrow, J.R. Crouse 3rd, W.H. Hinson Contribution of visceral fat mass to the insulin resistance of aging Metabolism 44 1995 954 959
3. D.M. Herrington, T.D. Howard, G.A. Hawkins, D.M. Reboussin, J. Xu, S.L. Zheng Estrogen-receptor polymorphisms and effects of estrogen replacement on high-density lipoprotein cholesterol in women with coronary disease N Engl J Med 346 2002 967 974
4. M. Falkeborn, I. Persson, H.O. Adami, R. Bergstrom, E. Eaker, H. Lithell The risk of acute myocardial infarction after oestrogen and oestrogen- progestogen replacement Br J Obstet Gynaecol 99 1992 821 828
5. S. Hulley, D. Grady, T. Bush, C. Furberg, D. Herrington, B. Riggs Heart and Estrogen/Progestin Replacement Study (HERS) Research Group Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women JAMA 280 1998 605 613
6. C.K. Sites Hormone replacement therapy cardiovascular benefits for aging women Coron Artery Dis 9 1998 789 793
7. J.P. Despres, A. Marette Relation of components of insulin resistance syndrome to coronary disease risk Curr Opin Lipidol 5 1994 274 289
8. N.H. Bjarnason, K. Bjarnason, J. Haarbo, H.J. Bennink, C. Christiansen Tibolone influence on markers of cardiovascular disease J Clin Endocrinol Metab 82 1997 1752 1756
9. D. Applebaum-Bowden, P. McLean, A. Steinmetz, D. Fontana, C. Matthys, G.R. Warnick Lipoprotein, apolipoprotein, and lipolytic enzyme changes following estrogen administration in postmenopausal women J Lipid Res 30 1989 1895 1906
10. H.J. Kloosterboer, L.J. Benedek Jaszmann, P.M. Kicovic Long-term effects of OrgOD14 on lipid metabolism in post-menopausal women Maturitas 12 1990 37 42
11. A. von Eckardstein, D. Crook, J. Elbers, J. Ragoobir, B. Ezeh, F. Helmond Tibolone lowers high density lipoprotein cholesterol by increasing hepatic lipase activity but does not impair cholesterol efflux Clin Endocrinol (Oxf) 58 2003 49 58
12. E. Farish, J.F. Barnes, C.D. Fletcher, K. Ekevall, A. Calder, D.M. Hart Effects of tibolone on serum lipoprotein and apolipoprotein levels compared with a cyclical estrogen/progestogen regimen Menopause 6 1999 98 104
13. G. Samsioe, C. Li, C. Borgfeldt, K. Wilawan, A. Aberg, S. Larsen Changes in lipid and lipoprotein profile in postmenopausal women receiving low-dose combinations of 17 beta-estradiol and norethisterone acetate Menopause 9 2002 335 342
14. S.M. Haffner, R.A. Valdez, H.P. Hazuda, B.D. Mitchell, P.A. Morales, M.P. Stern Prospective analysis of the insulin-resistance syndrome (syndrome X) Diabetes 41 1992 715 722
15. M.A. Espeland, P.E. Hogan, S.E. Fineberg, G. Howard, H. Schrott, M.A. Waclawiw PEPI Investigators Effect of postmenopausal hormone therapy on glucose and insulin concentrations. Postmenopausal Estrogen/Progestin Interventions Diabetes Care 21 1998 1589 1595
16. Writing Group for the PEPI Trial Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women the Postmenopausal Estrogen/Progestin Interventions (PEPI) trial JAMA 273 1995 199 208
17. R.A. Lobo, T. Bush, B.R. Carr, J.H. Pickar Effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate on plasma lipids and lipoproteins, coagulation factors, and carbohydrate metabolism Fertil Steril 76 2001 13 24
18. K. Saǧlam, Z. Polat, M.I. Yilmaz, M. Güleç, S.B. Akinci Effects of postmenopausal hormone replacement therapy on insulin resistance Endocrine 18 2002 211 214
19. A.M. Kanaya, D. Herrington, E. Vittinghoff, F. Lin, D. Grady, V. Bittner Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/Progestin Replacement Study. A randomized, double-blind, placebo-controlled trial Ann Intern Med 138 2003 1 9
20. A. Cagnacci, E. Mallus, F. Tuveri, R. Cirillo, A.M. Setteneri, G.B. Melis Effect of tibolone on glucose and lipid metabolism in postmenopausal women J Clin Endocrinol Metab 82 1997 251 253
21. I. Wiegratz, F. Starflinger, W. Tetzloff, B. Leifels-Fischer, F.A. Helmond, J.S. Dericks-Tan Effect of tibolone compared with sequential hormone replacement therapy on carbohydrate metabolism in postmenopausal women Maturitas 41 2002 133 141
22. G.M. Prelevic, T. Beljic, L. Balint-Peric, J. Ginsburg Metabolic effects of tibolone in postmenopausal women with non-insulin dependent diabetes mellitus Maturitas 28 1998 271 276
23. K.H. Polderman, L.J. Gooren, H. Asscheman, A. Bakker, R.J. Heine Induction of insulin resistance by androgens and estrogens J Clin Endocrinol Metab 79 1994 265 271
24. D. Thiebaud, R.A. DeFronzo, E. Jacot, A. Golay, K. Acheson, E. Maeder Effect of long chain triglyceride infusion on glucose metabolism in man Metabolism 31 1982 1128 1136
25. A.S. Ryan, B.J. Nicklas, D.M. Berman Hormone replacement therapy, insulin sensitivity, and abdominal obesity in postmenopausal women Diabetes Care 25 2002 127 133
26. G.F. Gensini, M. Comeglio, A. Colella Classical risk factors and emerging elements in the risk profile for coronary artery disease Eur Heart J 19 1998 53 61
27. J. Conard, A. Basdevant, J.L. Thomas, E. Ochsenbein, C. Denis, T.T. Guyene Cardiovascular risk factors and combined estrogen-progestin replacement therapy a placebo-controlled study with nomegestrol acetate and estradiol Fertil Steril 64 1995 957 962
28. L.F. Andersen, J. Gram, S.O. Skouby, J. Jespersen Effects of hormone replacement therapy on hemostatic cardiovascular risk factors Am J Obstet Gynecol 180 1999 283 289
29. C.M. Kessler, L.M. Szymanski, Z. Shamsipour, R.A. Muesing, V.T. Miller, J.C. LaRosa Estrogen replacement therapy and coagulation relationship to lipid and lipoprotein changes Obstet Gynecol 89 1997 326 331
30. Writing Group for the Estradiol Clotting Factors Study Effects on haemostasis of hormone replacement therapy with transdermal estradiol and oral sequential medroxyprogesterone acetate a 1-year, double-blind, placebo-controlled study Thromb Haemost 75 1996 476 480
31. C.A. DeSouza, E.T. Stevenson, K.P. Davy, P.P. Jones, D.R. Seals Plasma fibrinogen levels in healthy postmenopausal women physical activity and hormone replacement status J Gerontol A Biol Sci Med Sci 52 1997 294 298
32. G. Maresca, A. Di Blasio, R. Marchioli, G. Di Minno Measuring plasma fibrinogen to predict stroke and myocardial infarction. An update Arterioscler Thromb Vasc Biol 19 1999 1368 1377
33. E.J. Dunn, R.A. Ariens Fibrinogen and fibrin clot structure in diabetes Herz 29 2004 470 479
34. A.R. Folsom, K.K. Wu, E. Shahar, C.E. Davis The Atherosclerosis Risk in Communities (ARIC) Study Investigators Association of hemostatic variables with prevalent cardiovascular disease and asymptomatic carotid artery atherosclerosis Arterioscler Thromb 13 1993 1829 1836
35. M. Cushman, C. Legault, E. Barrett-Connor, M.L. Stefanick, C. Kessler, H.L. Judd Effect of postmenopausal hormones on inflammation-sensitive proteins the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study Circulation 100 1999 717 722
36. P.Y. Scarabin, A.M. Vissac, J.M. Kirzin, P. Bourgeat, J. Amiral, R. Agher Population correlates of coagulation factor VII. Importance of age, sex, and menopausal status as determinants of activated factor VII Arterioscler Thromb Vasc Biol 16 1996 1170 1176
37. P.M. Sarrel Cardiovascular disease in women implications of hormone replacement therapy Int J Fertil Menopausal Stud 41 1996 90 93
38. J. Cortes-Prieto Coagulation and fibrinolysis in post-menopausal women treated with Org OD 14 Maturitas Suppl 1 1987 67 72
39. D.E. Parkin, D. Smith, F.A. Azzawi, R. Lindsay, D.M. Hart Effects of long-term ORG OD 14 administration on blood coagulation in climacteric women Maturitas 9 1987 95 101
40. L.E. Rabbani, N.A. Seminario, R.R. Sciacca, H.J. Chen, E.G. Giardina Oral conjugated equine estrogen increases plasma von Willebrand factor in postmenopausal women J Am Coll Cardiol 40 2002 1991 1999
41. I. Mertens, L.F. Van Gaal Obesity, haemostasis and the fibrinolytic system Obes Rev 3 2002 85 101
42. J.E. Compston, M. Bhambhani, M.A. Laskey, S. Murphy, K.T. Khaw Body composition and bone mass in post-menopausal women Clin Endocrinol (Oxf) 37 1992 426 431
43. C.E. Ruhl, J.E. Everhart Relationship of serum leptin concentration with bone mineral density in the United States population J Bone Miner Res 17 2002 1896 1903
44. E. Barrett-Connor, D. Kritz-Silverstein Does hyperinsulinemia preserve bone? Diabetes Care 19 1996 1388 1392
45. R.J. Chang A practical approach to the diagnosis of polycystic ovary syndrome Am J Obstet Gynecol 191 2004 713 717
46. M. Doren, A. Rubig, H.J. Coelingh Bennink, W. Holzgreve Differential effects on the androgen status of postmenopausal women treated with tibolone and continuous combined estradiol and norethindrone acetate replacement therapy Fertil Steril 75 2001 554 559
47. B. Guerci, B. Verges, V. Durlach, S. Hadjadj, P. Drouin, J.L. Paul Relationship between altered postprandial lipemia and insulin resistance in normolipidemic and normoglucose tolerant obese patients Int J Obes Relat Metab Disord 24 2000 468 478
48. S.J. Wimalawansa Prevention and treatment of osteoporosis efficacy of combination of hormone replacement therapy with other antiresorptive agents J Clin Densitom 3 2000 187 201